CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 451 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 360 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 419 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 361 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 393 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 370 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 432 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 373 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 380 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 362 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 366 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 369 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 379 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 357 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 379 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 366 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 346 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 386 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 367 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 324 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 342 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 379 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 372 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 403 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvista 351 veces20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votos)
|
|
|
|
|
| 25 archivos en 1 página(s) |
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy